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S U M M A R Y
Background: Acinetobacter baumannii is considered a leading cause of nosocomial bloodstream infections
in intensive care units (ICUs), but there is disagreement as to whether certain invasive ICU procedures
increase the risk of this infection. To help address this question, we performed a systematic review of the
literature on whether previous catheterization (central venous, arterial, and urinary), mechanical
ventilation, nasogastric tube use, and abdominal or thoracic drainage are associated with the
development of A. baumannii nosocomial bacteremia in ICUs.
Methods: Two reviewers searched PubMed, EMBASE, and Medline for the period January 1999 to
February 2013. For each of seven invasive procedures, patients in the included studies were classiﬁed
into two groups: those who had previously undergone that procedure and those who had not. The
frequencies of A. baumannii nosocomial bacteremia were determined for each group.
Results: Five studies were included in the meta-analysis: three provided data for thoracic drainage, four
for abdominal drainage, and ﬁve for the other invasive procedures. The following prior interventions
were associated with an elevated risk of A. baumannii nosocomial bacteremia: mechanical ventilation
(odds ratio (OR) 4.79, 95% conﬁdence interval (CI) 3.09–7.43), central venous catheterization (OR 6.25,
95% CI 2.58–15.11), urinary catheterization (OR 2.55, 95% CI 1.49–4.36), and nasogastric tube use (OR
4.70, 95% CI 2.79–7.91).
Conclusions: Available evidence suggests that prior central venous or urinary catheterization,
mechanical ventilation, and nasogastric tube use are associated with a higher risk of A. baumannii
nosocomial bacteremia in the ICU.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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Acinetobacter baumannii, a non-fermenting Gram-negative
aerobic coccobacillus, is emerging as an important nosocomial
pathogen worldwide, especially in intensive care units (ICUs).1,2 In
recent years, it has been designated a ‘red alert’ human pathogen
and has caused considerable concern in the medical community.3
In fact, A. baumannii is considered a leading cause of nosocomial
bloodstream infections in ICUs.4–6 The clinical course of these* Corresponding author. Tel.: +86 23 8901 2369; fax: +86 23 6881 1487.
E-mail address: yuanzhe-1030@163.com (Z. Yuan).
http://dx.doi.org/10.1016/j.ijid.2014.01.018
1201-9712  2014 The Authors. Published by Elsevier Ltd on behalf of International Sobloodstream infections varies from benign transient bacteremia to
fulminant septic shock, with a crude mortality rate as high as 52%.2
Studies comparing ICU patients with and without A. baumannii
bloodstream infection have reported several risk factors for A.
baumannii nosocomial bacteremia, including organ failure, large
burn wound area, prior use of antibiotics, major surgical
procedures, immunosuppression, and prior chemo- or radiothera-
py.7–12 While some studies have also suggested the prior use of
invasive procedures to be a risk factor for A. baumannii nosocomial
bacteremia, the strength of this association is questionable
because studies have differed widely in design, sample size, and
patient age, as well as in which invasive procedures they have
analyzed and on whether they analyzed endemic colonization or
epidemic outbreaks.13 This highlights the need for more rigorousciety for Infectious Diseases. Open access under CC BY-NC-ND license.
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speciﬁc invasive procedures on the risk of A. baumannii nosocomial
bacteremia.
Therefore we performed a systematic review of the literature to
examine the association between the risk of A. baumannii
nosocomial bacteremia and seven invasive procedures: central
venous, arterial, and urinary catheterization; mechanical ventila-
tion; nasogastric tube use; and abdominal and thoracic drainage.
2. Methods
2.1. Search strategy
Both a specialist in infectious disease and a professional
epidemiologist searched PubMed, EMBASE, and Medline databases
using the following search terms to identify relevant studies
published in the period January 1999 to February 2013:
‘Acinetobacter baumannii’, ‘bacteremia OR bloodstream infection’,
‘risk factors OR predictors’. Results were limited to ‘All Adults’
without any language restriction. Reference lists in the selected
articles and relevant review articles were also searched to identify
additional studies. When multiple relevant abstracts from
scientiﬁc conferences were identiﬁed in the searches of the
literature databases, separate searches of all abstracts from those
conferences were conducted.
2.2. Study selection
Studies were selected if they (1) had a case–control or cohort
design, whether prospective or retrospective, or a randomized
controlled design; (2) diagnosed A. baumannii nosocomial bacter-
emia (or nosocomial bloodstream infection) according to the
criteria of the Centers for Disease Control and Prevention;14 and (3)
examined whether one or more of seven prior invasive procedures
(central venous, arterial or urinary catheterization; mechanical
ventilation; nasogastric tube use; abdominal or thoracic drainage)
was a risk factor or predictor for A. baumannii nosocomial
bacteremia in adult ICU patients. Studies examining patients in
general wards were excluded, as were case reports, reviews, and
comments or letters to the editor.
2.3. Data extraction
Data in the text, tables, and ﬁgures of the included studies were
extracted independently by two authors (ZY, HYZ) using a
standardized protocol and deﬁnitions. Disagreements were
resolved through discussion. For each of the seven invasive
procedures, patients in each study were classiﬁed into two groups:
those who had undergone that prior intervention and those who
had not. For each intervention, the proportions of patients in each
of the two groups who developed A. baumannii nosocomial
bacteremia were recorded.
2.4. Quality assessment of included studies
We assessed the quality of the included studies using the
Newcastle–Ottawa Scale (NOS) for case–control and cohort
studies.15 We developed an NOS-based scale for scoring the
studies (score range, 0–9 points).
2.5. Statistical analysis
The meta-analysis was performed using RevMan 5.2.7
(Cochrane Collaboration). Pooled odds ratios (ORs) and 95%
conﬁdence intervals (CIs) were calculated for all outcomes.
Statistical heterogeneity between studies was assessed using aChi-square test in which p < 0.10 was taken as the threshold of
signiﬁcant heterogeneity, or by calculating I2, with I2 50%
considered evidence of heterogeneity. The Mantel–Haenszel ﬁxed-
or random-effects method was used to perform a meta-analysis of
outcomes depending on the assessed heterogeneity. Furthermore,
subgroup meta-analyses were performed to address heterogeneity
when a sufﬁcient number of studies could be included.16
Publication bias was explored graphically using funnel plots.16
3. Results
Of the 258 relevant articles identiﬁed in the databases, 232
were excluded based on title and abstract screening and 21 were
excluded after reading the full text (Figure 1). The remaining ﬁve
studies were included in the ﬁnal meta-analysis, although not all
studies underwent meta-analysis for all invasive procedures. Key
characteristics of the included studies and the risk factors that they
assessed are presented in Table 1.
The studies had various designs: prospective cohort (one),
retrospective case–control (two), and retrospective, matched case–
control (two). The studies were of reasonably high quality: their
rating based on the NOS ranged from 7 to 9 points, with an average
score of 7 points (Table 2).
The ﬁve studies showed considerable overlap in the invasive
procedures that they examined, allowing us to include most or all
of them in meta-analyses of the various invasive procedures and
risk of A. baumannii nosocomial bacteremia (Table 3). Five studies
reported data on prior mechanical ventilation, and these data
underwent meta-analysis using a ﬁxed-effect model, since no
statistically signiﬁcant heterogeneity was found (I2 = 0%, p = 0.48).
The pooled OR for A. baumannii nosocomial bacteremia in patients
with prior mechanical ventilation relative to those without prior
ventilation was 4.79 (95% CI 3.09–7.43, p < 0.001). All ﬁve studies
also reported data on prior central venous catheterization, which
showed no statistically signiﬁcant heterogeneity (I2 = 0%, p = 0.92).
Fixed-effect meta-analysis gave a pooled OR of 6.25 (95% CI 2.58–
15.11, p < 0.001). Fixed-effect meta-analysis of data from all ﬁve
studies on prior urinary catheterization (I2 = 17%, P = 0.31) gave a
pooled OR of 2.55 (95% CI 1.49–4.36, p < 0.001). The same
approach was used to perform a meta-analysis of the nasogastric
tube data from the ﬁve studies (I2 = 23%, p = 0.27), giving a pooled
OR of 4.70 (95% CI 2.79–7.91, p < 0.001). While all ﬁve studies also
reported data on prior arterial catheterization, they showed
signiﬁcant heterogeneity (I2 = 67%, p = 0.02), so random-effects
meta-analysis was used to generate a pooled OR of 1.35 (95% CI
0.62–2.93, p = 0.44).
Given the heterogeneity among the studies examining prior
arterial catheterization, we performed subgroup analyses for that
procedure based on whether the study involved 100–400 patients
or numbers smaller or larger than this range, and on whether the
study involved patients admitted to the burn ICU or to non-burn
ICUs (Figure 2). Heterogeneity within each subgroup was lower
than in the original set of studies, especially among studies
analyzing 100–400 patients. The results were similar to those
obtained without study stratiﬁcation, suggesting that our results
are robust.
The ﬁve studies did not all report data on thoracic and
abdominal drainage. Data from three studies on thoracic drainage
showed signiﬁcant heterogeneity (I2 = 58%, p = 0.09), and so
underwent meta-analysis using a random-effects model to obtain
a pooled OR of 1.81 (95% CI 0.88–3.70, p = 0.10). Four studies
reported data on prior abdominal drainage that did not show
signiﬁcant heterogeneity (I2 = 10%, p = 0.34). Fixed-effect meta-
analysis gave a pooled OR of 1.13 (95% CI 0.71–1.78, p = 0.61).
In order to detect evidence of signiﬁcant publication bias, we
generated funnel plots of the meta-analysis for each of the seven
Potentially relevant articles identified in PubMed, EMBASE, and 
Medline searches and screened based on title and abstract (n= 258)
Articles assessed for eligibility based on full text  (n = 26)
Articles excluded  (n = 21) 
• Reported inadequate data  (n = 4) 
• Compared risk of carbapenem-resistant vs. carbapenem-susceptible 
Acinetobacter baumannii bacteremia (n = 4) 
• Compared risk of  A. baumannii vs. Klebsiella pneumoniae nosocomial 
bloodstream infections (n = 1) 
• Compared  A. baumannii vs. A. non-baumannii bacteremia ( n = 1) 
• Compared multidrug-resistant  A. baumannii bacteremia vs. 
non-multidr ug-re sistant  A. baumannii bacteremia ( n = 4) 
• Focused on mortality risk factors of  A. baumannii bacteremia ( n = 5) 
• Focused on  A. baumannii bacteremia in newborns ( n = 1) 
• Review article  (n = 1) 
Studies included in the meta-analyses (n = 5) 
Meta-analysis of prior central venous, arterial or 
urinary catheterization, mechanical ventilation, and 
nasogastric tube use (n = 5) 
Meta-analysis of prior abdominal 
drainage (n = 4)
Meta-an alysi s of  prio r thoracic drainage  (n = 3)
Figure 1. Flowchart of study selection for the meta-analysis.
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suggesting a lack of signiﬁcant publication bias.
4. Discussion
A. baumannii bacteremia is usually nosocomially acquired and it
occurs most often in the ICU.17 A review of nosocomial bacteremia
cases in the USA between 1995 and 2002 showed Acinetobacter to
account for 1.3% of all monomicrobial bloodstream infections; it
was found to cause 1.6% of all bloodstream infections in ICUs
compared to 0.9% of all bloodstream infections outside the ICU.18–
20 The higher prevalence among ICU patients likely reﬂects the fact
that these patients usually undergo more invasive procedures for
longer periods of time than do patients in other wards and also that
they frequently receive antimicrobial therapy.17 Our meta-analysisTable 1
Summary of studies included
Study Country Study period Design 
Garcı´a-Garmendia
et al., 20018
Spain Jan 1994–Dec 1995 Prospective cohort 
Wisplinghoff
et al., 19999
Germany Jan 1990– Dec 1992 Retrospective matche
case–control
Kim et al., 201210 South Korea Jan 2008–Dec 2009 Retrospective case–co
Jang et al., 200911 Taiwan Oct 1997–Sep 2006 Retrospective matche
case–control
Jung et al., 201012 South Korea Jan 2008–Dec 2009 Retrospective case–co
AB, Acinetobacter baumannii; MV, mechanical ventilation; AC, arterial catheterization; AD
TD, thoracic drainage; UC, urinary catheterization.of ﬁve studies involving 3392 patients in ICUs in four countries
provides strong evidence that at least four invasive procedures
frequently performed in the ICU elevate the risk of A. baumannii
nosocomial bacteremia: central venous or urinary catheterization,
mechanical ventilation, and nasogastric tube use. On the other
hand, the available evidence suggests that prior arterial catheteri-
zation and thoracic and abdominal drainage do not increase the
risk.
Previous work has suggested that A. baumannii nosocomial
bacteremia is opportunistic and therefore more likely to affect
patients who have undergone invasive procedures,17 yet studies on
the association between speciﬁc procedures and the risk of such
bacteremia have given inconsistent results. For example, some
studies have reported that prior central venous catheterization
increases the risk of A. baumannii nosocomial bacteremia, whereasn Invasive procedures Primary outcome
2640 MV, CVC, UC, AC,
NT, TD, AD
AB nosocomial bacteremia or no
AB bacteremia
d 87 MV, CVC, UC,
AC, NT
AB nosocomial bacteremia or no
AB bacteremia
ntrol 311 MV, CVC, UC, AC,
NT, TD, AD
Carbapenem-resistant AB nosocomial
bacteremia or no AB bacteremia
d 154 MV, CVC, UC, AC,
NT, AD
AB nosocomial bacteremia or no
AB bacteremia
ntrol 200 MV, CVC, UC, AC,
NT, TD, AD
Multidrug-resistant AB nosocomial
bacteremia or no AB bacteremia
, abdominal drainage; CVC, central venous catheterization; NT, nasogastric tube use;
Table 2
Quality of included studies based on the Newcastle–Ottawa Scale (NOS), with ratings assigned on a 9-point scale
(a) Case–control studies
Study Selection rating (points) Comparability
rating (points)
Exposure rating (points) Total
points
Adequate
deﬁnition
of case
Representativeness
of cases
Selection of
controls
Deﬁnition of
controls
Controls for important
factor or additional
factor
Ascertainment
of exposure
Same ascertainment
of cases and
controls
Non-
response rate
Wisplinghoff
et al.9
1 1 1 1 2 1 1 1 9
Kim et al.10 1 1 1 1 0 1 1 1 7
Jang et al.11 1 1 1 1 2 1 1 1 9
Jung et al.12 1 1 1 1 0 1 1 1 7
(b) Cohort studies
Study Selection rating (points) Comparability
rating (points)
Outcome rating (points) Total
points
Representativeness
of exposed cohort
Selection of
non-exposed
cohort
Ascertainment
of exposure
Outcome of
interest absent
at start of study
Controls for
important factor
or additional
factor
Assessment
of outcome
Follow-up
long enough
for outcomes
to occur
Adequacy of
follow-up of
cohorts
Garcı´a-Garmendia et al.8 1 1 1 1 0 1 1 1 7
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have shown that urinary catheterization increases the risk of A.
baumannii nosocomial bacteremia, while other studies have failed
to ﬁnd such an association.8–12 These discrepancies may reﬂect
differences in the source of patients or the sample size, or an
overall lack of statistical power. This led us to undertake the
present systematic review in order to assess the associations as
reliably and comprehensively as possible.Table 3
Meta-analyses of the association between the seven types of invasive procedure and t
Invasive procedure Meta-analyzed studies Statistical he
neity
I2
Mechanical ventilation Garcı´a-Garmendia et al.8
Wisplinghoff et al.9
Kim et al.10
Jang et al.11
Jung et al.12
0% 
Central venous catheterization Garcı´a-Garmendia, et al.8
Wisplinghoff et al.9
Kim et al.10
Jang et al.11
Jung et al.12
0% 
Urinary catheterization Garcı´a-Garmendia et al.8
Wisplinghoff et al.9
Kim et al.10
Jang et al.11
Jung et al.12
17% 
Nasogastric tube Garcı´a-Garmendia et al.8
Wisplinghoff et al.9
Kim et al.10
Jang et al.11
Jung et al.12
23% 
Arterial catheterization Garcı´a-Garmendia et al.8
Wisplinghoff et al.9
Kim et al.10
Jang et al.11
Jung et al.12
67% 
Thoracic drainage Garcı´a-Garmendia et al.8
Kim et al.10
Jung et al.12
58% 
Abdominal drainage Garcı´a-Garmendia et al.8
Kim et al.10
Jang et al.11
Jung et al.12
10% 
ICUs, intensive care units; OR, odds ratio; 95% CI, 95% conﬁdence interval.
a Statistically signiﬁcant differences between groups (a = 0.05).Our ﬁndings are consistent with those of studies showing that
A. baumannii bacteremia frequently occurs secondary to infections
in the lungs, vein catheters, and abdomen.21,22 Although rarely
found as part of the normal skin microﬂora,23 A. baumannii can
adhere to surfaces, and it speciﬁcally targets moist tissues such as
mucous membranes or skin that has been exposed due to accident
or injury.18,24 Invasive procedures also destroy intact skin and
therefore probably create conditions for A. baumannii to colonizehe risk of Acinetobacter baumannii nosocomial bacteremia in ICUs
teroge- Fixed- or random-
effects model
Pooled OR (95% CI) p-Value
p-Value
0.48 Fixed 4.79 (3.09, 7.43) <0.00001a
0.92 Fixed 6.25 (2.58, 15.11) <0.0001a
0.31 Fixed 2.55 (1.49, 4.36) 0.0006a
0.27 Fixed 4.70 (2.79, 7.91) <0.00001a
0.02 Random 1.35 (0.62, 2.93) 0.44
0.09 Random 1.81 (0.88, 3.70) 0.10
0.34 Fixed 1.13 (0.71, 1.78) 0.61
(a) Subgroup meta-analyses based on sample size 
Study or Subgroup
1.2.1 Studies analyzing 100-400 patients
Jang 2009
Jung 2010
Kim 2012
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.06; Chi² = 2.72, df = 2 (P = 0.26); I² = 26%
Test for overall effect: Z = 1.52 (P = 0.13)
1.2.2 Studies analyzing >400 patients
García-Garmendia 2001
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 1.51 (P = 0.13)
1.2.3 Studies analyzing <100 patients
Wisplinghoff 1999
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 2.37 (P = 0.02)
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.47; Chi² = 12.26, df = 4 (P = 0.02); I² = 67%
Test for overall effect: Z = 0.76 (P = 0.44)
Chi²differences:subgroupforTest = df9.12, = (P 2 = I²0.01), = 78.1%
Events
44
96
97
237
4
4
29
29
270
Total
76
180
272
528
496
496
67
67
1091
Events
33
12
9
54
38
38
0
0
92
Total
78
20
39
137
2144
2144
20
20
2301
Weight
26.8%
22.1%
24.5%
73.3%
20.6%
20.6%
6.0%
6.0%
100.0%
M-H, Random, 95% CI
1.88 [0.99, 3.55]
0.76 [0.30, 1.95]
1.85 [0.84, 4.05]
1.50 [0.89, 2.52]
0.45 [0.16, 1.27]
0.45 [0.16, 1.27]
31.42 [1.82, 540.99]
31.42 [1.82, 540.99]
1.35 [0.62, 2.93]
Year
2009
2010
2012
2001
1999
Odds RatioOdds RatioNon-ACAC
M-H, Random, 95% CI
0.002 0.1 1 10 500
Non-ACAC
(b) Subgroup meta-a nalyses based on source of patients 
Study or Subgroup
2.2.1 Study with patients admitted to the burn intensive care unit (BICU)
Wisplinghoff 1999
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 2.37 (P = 0.02)
2.2.2 Studies with patients admitted to non-burn ICUs
García-Garmendia 2001
Jang 2009
Jung 2010
Kim 2012
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.26; Chi² = 7.33, df = 3 (P = 0.06); I² = 59%
Test for overall effect: Z = 0.38 (P = 0.70)
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.47; Chi² = 12.26, df = 4 (P = 0.02); I² = 67%
Test for overall effect: Z = 0.76 (P = 0.44)
Chi²differences:subgroupforTest = df4.97, = (P 1 = I²0.03), = 79.9%
Events
29
29
4
44
96
97
241
270
Total
67
67
496
76
180
272
1024
1091
Events
0
0
38
33
12
9
92
92
Total
20
20
2144
78
20
39
2281
2301
Weight
6.0%
6.0%
20.6%
26.8%
22.1%
24.5%
94.0%
100.0%
M-H, Random, 95% CI
31.42 [1.82, 540.99]
31.42 [1.82, 540.99]
0.45 [0.16, 1.27]
1.88 [0.99, 3.55]
0.76 [0.30, 1.95]
1.85 [0.84, 4.05]
1.14 [0.59, 2.18]
1.35 [0.62, 2.93]
Year
1999
2001
2009
2010
2012
Odds RatioOdds RatioNon-ACAC
M-H, Random, 95% CI
0.002 0.1 1 10 500
Non-ACAC
Figure 2. Forest plots of subgroup meta-analyses depicting odds ratios (ORs) for the risk of Acinetobacter baumannii nosocomial bacteremia in ICUs due to prior use of an
arterial catheter (AC).
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addition, studies have shown that A. baumannii can form bioﬁlms
not only on abiotic surfaces such as glass and other ICU equipment,
but also on biotic surfaces such as epithelial cells,25 increasing its
pathogenic potential. Thus we speculate that A. baumannii can
adhere to the surface of central venous or urinary catheters,
endotracheal tubes, and nasogastric tubes, where it can form
bioﬁlms that can migrate from the external to internal surface of
the device, ultimately reaching epithelial cells,22 where it can
cause infection. Indeed bioﬁlms of A. baumannii can form especially
rapidly on endotracheal tubes,26 which may help to explain the
nearly ﬁve-fold higher risk of bacteremia due to prior mechanical
ventilation in our meta-analysis. The more than six-fold higher risk
associated with central venous catheterization may reﬂect the fact
that A. baumannii contaminating such a catheter easily gains direct
access to deep veins. On the other hand, arterial catheterization
also invades blood vessels, yet our meta-analysis suggests that it
does not signiﬁcantly increase the risk of A. baumannii bacteremia.
This may be because the technique is performed for relatively short
periods; for example, one study8 reported a median duration of 0
days (interquartile range, 0–0 days). Similarly, a relatively short
duration may explain our ﬁnding that prior thoracic and
abdominal drainage do not elevate the risk of A. baumannii
bacteremia, although this may also reﬂect the fact that material in
the drainage tubes ﬂows away from the body rather than into it.
Our ﬁndings emphasize the importance of carefully considering
whether central venous or urinary catheterization, mechanical
ventilation, and nasogastric tube use are justiﬁed in light of the
increased risk of A. baumannii nosocomial bacteremia. Given the
importance of these interventions for intensive care medicine in
general, future research is needed to examine how the risk of A.
baumannii nosocomial bacteremia varies with the duration of
these procedures.
Although our meta-analysis gave clear results, our ﬁndings
should be interpreted with caution given that only three to ﬁve
studies were used to assess each invasive procedure. Indeed,
signiﬁcant heterogeneity between studies was detected for certain
invasive procedures. To address heterogeneity and test the
robustness of our overall pooled meta-analysis for arterial
catheterization, we performed subgroup analyses in which we
stratiﬁed studies based on sample size (100–400 patients or
numbers outside this range) and the source of patients (burn or
non-burn ICU). The subgroup meta-analyses gave results similar to
the overall pooled meta-analysis. Therefore we believe that our
results are reliable, though heterogeneity remains a problem for
some procedures, especially thoracic drainage, for which too few
studies were available to perform a subgroup analysis. Most of the
studies included in our systematic review were retrospective in
design and all were observational, increasing the risk of patient
selection bias, outcome reporting bias, and confounding. On the
other hand, all studies received reasonably high quality scores on
the NOS. Nevertheless, more large, prospective, and well-
controlled studies are needed to analyze factors affecting the risk
of A. baumannii nosocomial bacteremia.
In conclusion, our meta-analysis suggests that four invasive
procedures frequently used in the ICU increase the risk of A.
baumannii bacteremia: central venous or urinary catheterization,
mechanical ventilation, and nasogastric tube use. This is particu-
larly true for mechanical ventilation and central venous catheteri-
zation. Studies are urgently needed on how the risk of A. baumannii
nosocomial bacteremia varies with the duration of these and other
invasive procedures.
Conﬂict of interest: No conﬂict of interest to declare.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ijid.2014.01.018.
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